DANIKA DAVILA: Open Payments
NPI 1952914087 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,492 in 129 payments from 13 companies in 2025. Trend: 2023 $2,548 · 2024 $2,397 · 2025 $2,492
Food & beverage: $2,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $501 |
| Janssen Biotech, Inc. | 19 | $462 |
| Ardelyx, Inc. | 13 | $304 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $285 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $239 |
| Madrigal Pharmaceuticals | 6 | $190 |
| QOL Medical, LLC | 7 | $180 |
| PFIZER INC. | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 4 | $78 |
| Ipsen Biopharmaceuticals, Inc | 3 | $65 |
Products named: TREMFYA, IBSRELA, XIFAXAN, ENTYVIO, REZDIFFRA, Sucraid, SKYRIZI, VIBERZI.
Industry payments across TX — which companies pay providers there.
